Cargando…
1,2,3,4-Tetrahydro-1,4-methanonaphthalene-2,3-diol
The title compound, C(11)H(12)O(2), is an intermediate in the synthesis of Varenicline, a nicotinic receptor partial agonist used to treat smoking addiction. In the crystal structure, there is an intramolecular O—H⋯O hydrogen bond that generates an S(5) ring motif. Intermolecular O—H⋯O hydrogen b...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
International Union of Crystallography
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967988/ https://www.ncbi.nlm.nih.gov/pubmed/21581717 http://dx.doi.org/10.1107/S1600536808041068 |